Thus, NOX2 may provide a therapeutic target to prevent obesity, for example, in the context of sleep disorders such as chronic sleep fragmentation that induces obesity in mice [133]. The gene discussed is CYBB; the disease is obesity due to melanocortin 4 receptor deficiency.